The novel treatment of this peptide represents a major advance in the care of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide066751.wssblogs.com/41903514/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment